IRIS
SCIONTI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 756
EU - Europa 542
AS - Asia 381
AF - Africa 21
SA - Sud America 17
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 720
IT - Italia 305
SG - Singapore 197
GB - Regno Unito 70
IN - India 42
CN - Cina 41
DE - Germania 31
SE - Svezia 29
CA - Canada 27
NL - Olanda 24
JO - Giordania 21
PK - Pakistan 17
FI - Finlandia 16
HK - Hong Kong 13
ES - Italia 11
ID - Indonesia 11
RU - Federazione Russa 11
FR - Francia 9
SA - Arabia Saudita 9
BR - Brasile 8
CZ - Repubblica Ceca 8
EG - Egitto 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
PT - Portogallo 6
ZA - Sudafrica 6
IE - Irlanda 5
IR - Iran 5
MX - Messico 5
CY - Cipro 4
BG - Bulgaria 3
ET - Etiopia 3
LB - Libano 3
NG - Nigeria 3
PE - Perù 3
CO - Colombia 2
EC - Ecuador 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
IQ - Iraq 1
NZ - Nuova Zelanda 1
UA - Ucraina 1
VN - Vietnam 1
Totale 1.727
Salva come PNG Salva come JPEG
Città #
Chandler 161
Singapore 110
Santa Clara 54
Chicago 51
London 44
Ashburn 39
Milan 36
Lawrence 34
Princeton 34
Catanzaro 27
Ottawa 19
Boardman 16
Helsinki 16
Wilmington 15
Amman 13
San Nicola Manfredi 12
Rome 11
Spezzano della Sila 10
Hong Kong 9
Munich 9
Delhi 8
Irbid 8
Madrid 8
Palermo 8
Cosenza 7
Kaunas 7
Los Angeles 7
Des Moines 6
Ercolano 6
Olomouc 6
Redmond 6
Aversa 5
Cardiff 5
Lucknow 5
Meppel 5
Naples 5
Riyadh 5
Sacramento 5
Santo Stefano di Rogliano 5
Ahmedabad 4
Beijing 4
Brescia 4
Cape Town 4
Catania 4
Frankfurt am Main 4
Hyderabad 4
Jeddah 4
Lahore 4
New York 4
Nicosia 4
Pune 4
San Francisco 4
Seattle 4
Toronto 4
Acquaviva delle Fonti 3
Addis Ababa 3
Afragola 3
Ajman 3
Andover 3
Banyumas 3
Berlin 3
Bristol 3
Castrovillari 3
Decollatura 3
Dubai 3
Guangzhou 3
Hanover 3
Islamabad 3
Lima 3
Melbourne 3
Mileto 3
Mountain View 3
Oristano 3
Oxford 3
Paola 3
Parma 3
Quţūr 3
Redwood City 3
Richmond 3
San Antonio 3
Santo Tirso 3
Shanghai 3
Sofia 3
Waterford 3
6th of October City 2
Agrigento 2
Amsterdam 2
Asyut 2
Augusta 2
Bari 2
Bekasi 2
Bogotá 2
Bologna 2
Campobello di Licata 2
Chennai 2
Colombo 2
Cropani 2
Dublin 2
Edmonton 2
Fayetteville 2
Totale 1.019
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 309
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 73
miR-22 suppresses DNA ligase III addiction in multiple myeloma 73
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis 53
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 52
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 51
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 49
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 47
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 45
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 43
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 42
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 41
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 39
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 36
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 35
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 35
Mmrf-commpass data integration and analysis for identifying prognostic markers 34
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 33
GENETIC SUSCEPTIBILITY TO GASTROINTESTINAL SYMPTOMS IN FABRY DISEASE 33
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 32
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 32
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 32
null 31
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 30
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 30
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 29
Integration of DNA Microarray with Clinical and Genomic Data 29
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 28
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 28
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 26
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine 26
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 26
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 24
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 24
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 23
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 22
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 22
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy. (IF 5.168) 21
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 20
Exploring the impact of lipid droplets on the evolution and progress of hepatocarcinoma 18
Ethical Perspectives on Pharmacogenomic Profiling 17
The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders 17
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 17
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 14
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 14
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 14
The potential role of miRNAs in multiple myeloma therapy 12
Functional Role of Linc-RNAs in Multiple Myeloma: Linc-MIR17HG Affects Fatty Acid Biosynthesis Via transcriptional Regulation of ACC1 with Potential Therapeutic Implications 12
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 10
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 9
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 9
Advances in Alport syndrome diagnosis using next-generation sequencing 9
High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndrome 7
The Effect of Physical Activity/Exercise on miRNA Expression and Function in Non-Communicable Diseases-A Systematic Review 6
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 5
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 4
Totale 1.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.051
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 0 0 0 0 0 0 18 18
2020/202163 8 1 2 6 5 6 6 7 9 12 1 0
2021/2022156 1 0 0 32 8 0 8 29 36 19 17 6
2022/2023453 75 31 22 19 59 40 7 33 60 33 49 25
2023/2024511 91 40 46 35 48 74 28 41 10 17 31 50
2024/2025610 92 33 33 50 62 126 73 60 56 23 2 0
Totale 1.852